| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myelodysplastic Syndromes | 60 | 2024 | 1392 | 9.880 |
Why?
|
| Hematopoiesis | 56 | 2023 | 2047 | 7.050 |
Why?
|
| Hematologic Neoplasms | 28 | 2023 | 1890 | 4.590 |
Why?
|
| Thalidomide | 17 | 2024 | 884 | 4.440 |
Why?
|
| Leukemia, Myeloid, Acute | 47 | 2024 | 3599 | 4.430 |
Why?
|
| Hematopoietic Stem Cells | 46 | 2024 | 3384 | 3.840 |
Why?
|
| Dioxygenases | 19 | 2024 | 332 | 3.670 |
Why?
|
| Mutation | 97 | 2024 | 29915 | 3.370 |
Why?
|
| Myeloproliferative Disorders | 17 | 2024 | 606 | 2.740 |
Why?
|
| Chromosomes, Human, Pair 5 | 18 | 2022 | 385 | 2.480 |
Why?
|
| Ubiquitin-Protein Ligases | 17 | 2024 | 1887 | 2.480 |
Why?
|
| Tumor Suppressor Protein p53 | 30 | 2024 | 2912 | 2.300 |
Why?
|
| Ribosomal Proteins | 15 | 2019 | 363 | 2.270 |
Why?
|
| Janus Kinase 2 | 17 | 2024 | 537 | 1.990 |
Why?
|
| Chromosome Deletion | 19 | 2022 | 1387 | 1.990 |
Why?
|
| Erythropoiesis | 15 | 2020 | 682 | 1.960 |
Why?
|
| Precancerous Conditions | 7 | 2023 | 977 | 1.950 |
Why?
|
| Anemia, Diamond-Blackfan | 13 | 2021 | 136 | 1.770 |
Why?
|
| Ubiquitination | 11 | 2024 | 1006 | 1.610 |
Why?
|
| Clone Cells | 8 | 2019 | 1660 | 1.570 |
Why?
|
| Neoplastic Stem Cells | 10 | 2018 | 1346 | 1.570 |
Why?
|
| Ribosomes | 6 | 2013 | 501 | 1.560 |
Why?
|
| Leukemia | 10 | 2022 | 1519 | 1.520 |
Why?
|
| Casein Kinase Ialpha | 5 | 2021 | 26 | 1.510 |
Why?
|
| Neoplasms, Second Primary | 7 | 2024 | 1056 | 1.470 |
Why?
|
| Proto-Oncogene Proteins | 19 | 2024 | 4485 | 1.460 |
Why?
|
| DNA-Binding Proteins | 29 | 2024 | 9574 | 1.320 |
Why?
|
| Anemia, Macrocytic | 7 | 2019 | 53 | 1.280 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 3 | 2022 | 264 | 1.250 |
Why?
|
| Casein Kinase I | 4 | 2018 | 46 | 1.250 |
Why?
|
| Point Mutation | 7 | 2018 | 1593 | 1.210 |
Why?
|
| Blood | 3 | 2022 | 586 | 1.190 |
Why?
|
| Haploinsufficiency | 7 | 2022 | 327 | 1.170 |
Why?
|
| Multiple Myeloma | 10 | 2024 | 5129 | 1.100 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 13 | 2020 | 5649 | 1.080 |
Why?
|
| Chromosome Aberrations | 13 | 2022 | 1763 | 1.060 |
Why?
|
| Spliceosomes | 3 | 2018 | 129 | 1.040 |
Why?
|
| Histone-Lysine N-Methyltransferase | 4 | 2022 | 677 | 1.030 |
Why?
|
| Mice | 101 | 2024 | 81101 | 1.030 |
Why?
|
| Humans | 297 | 2024 | 758406 | 1.020 |
Why?
|
| Animals | 145 | 2024 | 167768 | 1.020 |
Why?
|
| Erythroid Precursor Cells | 6 | 2016 | 211 | 0.980 |
Why?
|
| Inflammasomes | 5 | 2024 | 527 | 0.980 |
Why?
|
| Erythroid Cells | 10 | 2017 | 235 | 0.950 |
Why?
|
| DNA Damage | 7 | 2023 | 2439 | 0.920 |
Why?
|
| Lymphoma, Non-Hodgkin | 3 | 2024 | 1373 | 0.920 |
Why?
|
| Histone Deacetylase Inhibitors | 3 | 2015 | 772 | 0.880 |
Why?
|
| Bone Marrow Neoplasms | 2 | 2014 | 101 | 0.860 |
Why?
|
| Bone Marrow | 14 | 2023 | 2909 | 0.850 |
Why?
|
| Cytokine Receptor Common beta Subunit | 1 | 2022 | 22 | 0.840 |
Why?
|
| Fetal Hemoglobin | 3 | 2015 | 342 | 0.840 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 2 | 2022 | 92 | 0.820 |
Why?
|
| Peptide Termination Factors | 1 | 2022 | 56 | 0.810 |
Why?
|
| Cell Transformation, Neoplastic | 11 | 2020 | 2825 | 0.810 |
Why?
|
| Cyclins | 2 | 2023 | 593 | 0.790 |
Why?
|
| Polymerization | 2 | 2024 | 157 | 0.750 |
Why?
|
| Atherosclerosis | 8 | 2024 | 3401 | 0.730 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2021 | 120 | 0.730 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2021 | 76 | 0.730 |
Why?
|
| RNA Interference | 8 | 2016 | 2836 | 0.730 |
Why?
|
| Hydroxyurea | 4 | 2015 | 282 | 0.710 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2020 | 191 | 0.700 |
Why?
|
| Primary Myelofibrosis | 5 | 2017 | 208 | 0.700 |
Why?
|
| Aging | 7 | 2024 | 8650 | 0.700 |
Why?
|
| Transcription Factors | 17 | 2024 | 12094 | 0.700 |
Why?
|
| Anemia, Sickle Cell | 5 | 2015 | 1054 | 0.690 |
Why?
|
| Drug Resistance, Neoplasm | 10 | 2021 | 5249 | 0.690 |
Why?
|
| Polycythemia Vera | 5 | 2013 | 160 | 0.690 |
Why?
|
| Gene Deletion | 6 | 2020 | 2666 | 0.680 |
Why?
|
| Giant Cell Arteritis | 1 | 2024 | 297 | 0.680 |
Why?
|
| Cyclin-Dependent Kinase 9 | 2 | 2021 | 67 | 0.680 |
Why?
|
| Cell Differentiation | 22 | 2021 | 11471 | 0.670 |
Why?
|
| Genomics | 11 | 2023 | 5790 | 0.670 |
Why?
|
| RNA Splicing | 4 | 2021 | 913 | 0.660 |
Why?
|
| Repressor Proteins | 11 | 2024 | 2980 | 0.660 |
Why?
|
| Antineoplastic Agents | 16 | 2023 | 13591 | 0.660 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 5 | 2024 | 300 | 0.650 |
Why?
|
| Neoplasms | 22 | 2022 | 22032 | 0.640 |
Why?
|
| Antisickling Agents | 3 | 2015 | 72 | 0.640 |
Why?
|
| Cardiovascular Diseases | 10 | 2024 | 15399 | 0.630 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 2020 | 655 | 0.630 |
Why?
|
| Phosphoproteins | 6 | 2020 | 2433 | 0.630 |
Why?
|
| Cell Line, Tumor | 32 | 2023 | 16886 | 0.630 |
Why?
|
| src-Family Kinases | 1 | 2021 | 535 | 0.620 |
Why?
|
| Chromosomal Proteins, Non-Histone | 3 | 2021 | 727 | 0.610 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2020 | 219 | 0.610 |
Why?
|
| Leukemia, Experimental | 2 | 2017 | 225 | 0.610 |
Why?
|
| Disease Models, Animal | 27 | 2023 | 18119 | 0.600 |
Why?
|
| Sequence Deletion | 7 | 2018 | 1492 | 0.600 |
Why?
|
| Erythroblasts | 2 | 2015 | 143 | 0.590 |
Why?
|
| Ikaros Transcription Factor | 4 | 2020 | 231 | 0.590 |
Why?
|
| Histone Deacetylase 2 | 2 | 2015 | 72 | 0.580 |
Why?
|
| Epigenesis, Genetic | 12 | 2021 | 3754 | 0.580 |
Why?
|
| Cell Cycle Proteins | 6 | 2024 | 3442 | 0.580 |
Why?
|
| Stem Cell Niche | 5 | 2016 | 345 | 0.570 |
Why?
|
| gamma-Globins | 2 | 2015 | 96 | 0.570 |
Why?
|
| Chromatin | 3 | 2024 | 2938 | 0.570 |
Why?
|
| Bone Marrow Cells | 10 | 2016 | 2414 | 0.560 |
Why?
|
| Histone Deacetylase 1 | 2 | 2015 | 134 | 0.560 |
Why?
|
| Nuclear Proteins | 14 | 2022 | 5786 | 0.550 |
Why?
|
| Purines | 1 | 2020 | 605 | 0.550 |
Why?
|
| Cell Cycle | 5 | 2023 | 2930 | 0.550 |
Why?
|
| Calgranulin A | 2 | 2019 | 80 | 0.550 |
Why?
|
| Mutation, Missense | 7 | 2021 | 2564 | 0.550 |
Why?
|
| DNA Mutational Analysis | 13 | 2020 | 4106 | 0.550 |
Why?
|
| Mice, Knockout | 18 | 2024 | 14354 | 0.540 |
Why?
|
| Selection, Genetic | 3 | 2020 | 868 | 0.530 |
Why?
|
| Pancytopenia | 2 | 2019 | 101 | 0.530 |
Why?
|
| Base Sequence | 18 | 2018 | 12436 | 0.530 |
Why?
|
| RNA Precursors | 2 | 2015 | 212 | 0.520 |
Why?
|
| CLOCK Proteins | 1 | 2016 | 86 | 0.520 |
Why?
|
| Gene Expression Regulation | 20 | 2024 | 11892 | 0.520 |
Why?
|
| K562 Cells | 6 | 2021 | 639 | 0.510 |
Why?
|
| ARNTL Transcription Factors | 1 | 2016 | 94 | 0.510 |
Why?
|
| Ribonucleoproteins | 2 | 2015 | 372 | 0.510 |
Why?
|
| Calgranulin B | 1 | 2016 | 86 | 0.510 |
Why?
|
| Leucine | 3 | 2014 | 547 | 0.510 |
Why?
|
| Genetic Predisposition to Disease | 15 | 2022 | 17768 | 0.500 |
Why?
|
| Gout | 1 | 2022 | 618 | 0.500 |
Why?
|
| Review Literature as Topic | 1 | 2017 | 348 | 0.490 |
Why?
|
| Prognosis | 26 | 2024 | 29557 | 0.490 |
Why?
|
| DNA Repair | 2 | 2022 | 2038 | 0.490 |
Why?
|
| Alleles | 7 | 2020 | 6895 | 0.480 |
Why?
|
| Erythropoietin | 13 | 2010 | 719 | 0.480 |
Why?
|
| Anemia | 4 | 2022 | 1504 | 0.470 |
Why?
|
| Ascorbic Acid | 1 | 2017 | 655 | 0.460 |
Why?
|
| Hodgkin Disease | 2 | 2024 | 1377 | 0.460 |
Why?
|
| Proteasome Endopeptidase Complex | 4 | 2024 | 1312 | 0.460 |
Why?
|
| HLA Antigens | 1 | 2019 | 1368 | 0.450 |
Why?
|
| Protein Kinase Inhibitors | 10 | 2019 | 5629 | 0.450 |
Why?
|
| Hematology | 1 | 2017 | 241 | 0.450 |
Why?
|
| Research Personnel | 1 | 2018 | 582 | 0.450 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2021 | 2443 | 0.440 |
Why?
|
| Integrin beta3 | 2 | 2013 | 120 | 0.440 |
Why?
|
| Mice, Mutant Strains | 6 | 2021 | 1751 | 0.440 |
Why?
|
| ras Proteins | 3 | 2017 | 1049 | 0.440 |
Why?
|
| Transplantation, Autologous | 6 | 2024 | 2114 | 0.440 |
Why?
|
| Mice, Inbred C57BL | 20 | 2024 | 22003 | 0.420 |
Why?
|
| Telomere | 3 | 2020 | 931 | 0.410 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 | 2024 | 1547 | 0.410 |
Why?
|
| Proteins | 8 | 2024 | 6026 | 0.410 |
Why?
|
| Hydroxamic Acids | 1 | 2015 | 481 | 0.410 |
Why?
|
| Exons | 5 | 2019 | 2387 | 0.400 |
Why?
|
| Adaptor Proteins, Signal Transducing | 7 | 2024 | 2895 | 0.400 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2021 | 2858 | 0.400 |
Why?
|
| MicroRNAs | 10 | 2020 | 3783 | 0.400 |
Why?
|
| Hemoglobin, Sickle | 1 | 2012 | 113 | 0.400 |
Why?
|
| Osteoporosis | 1 | 2021 | 1598 | 0.390 |
Why?
|
| Lymphoma | 3 | 2021 | 1896 | 0.380 |
Why?
|
| Genes, Neurofibromatosis 1 | 2 | 2013 | 74 | 0.380 |
Why?
|
| HEK293 Cells | 11 | 2024 | 4257 | 0.380 |
Why?
|
| Neoplasm Proteins | 4 | 2018 | 3609 | 0.380 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2012 | 3774 | 0.370 |
Why?
|
| Atrial Fibrillation | 3 | 2024 | 5103 | 0.370 |
Why?
|
| Dexamethasone | 2 | 2011 | 1927 | 0.370 |
Why?
|
| Pyridines | 2 | 2020 | 2859 | 0.370 |
Why?
|
| Molecular Targeted Therapy | 4 | 2021 | 2796 | 0.370 |
Why?
|
| STAT Transcription Factors | 4 | 2018 | 188 | 0.370 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2019 | 601 | 0.360 |
Why?
|
| Lipomatosis | 1 | 2011 | 112 | 0.360 |
Why?
|
| Enzyme Inhibitors | 3 | 2018 | 3709 | 0.360 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 2011 | 84 | 0.360 |
Why?
|
| Signal Transduction | 17 | 2021 | 23342 | 0.360 |
Why?
|
| Small Molecule Libraries | 4 | 2020 | 724 | 0.360 |
Why?
|
| Amino Acid Substitution | 5 | 2013 | 1734 | 0.360 |
Why?
|
| Antigens, CD34 | 7 | 2017 | 653 | 0.360 |
Why?
|
| Ligands | 7 | 2023 | 3258 | 0.350 |
Why?
|
| Gene Expression Profiling | 19 | 2016 | 9404 | 0.350 |
Why?
|
| Quinazolines | 2 | 2017 | 1360 | 0.340 |
Why?
|
| Leukemia, Erythroblastic, Acute | 2 | 2021 | 176 | 0.340 |
Why?
|
| T-Lymphocytes | 7 | 2024 | 10171 | 0.340 |
Why?
|
| Bone Marrow Diseases | 1 | 2011 | 232 | 0.340 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2021 | 1627 | 0.330 |
Why?
|
| Hematologic Diseases | 1 | 2013 | 496 | 0.330 |
Why?
|
| Phenotype | 19 | 2023 | 16534 | 0.330 |
Why?
|
| Fanconi Anemia | 2 | 2023 | 324 | 0.330 |
Why?
|
| Isoxazoles | 9 | 1998 | 230 | 0.330 |
Why?
|
| Pyrimidines | 5 | 2019 | 3006 | 0.330 |
Why?
|
| Male | 71 | 2024 | 358747 | 0.330 |
Why?
|
| Angiogenesis Inhibitors | 3 | 2017 | 2047 | 0.330 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2021 | 8506 | 0.330 |
Why?
|
| Female | 73 | 2024 | 390323 | 0.320 |
Why?
|
| Transcription, Genetic | 14 | 2020 | 7590 | 0.320 |
Why?
|
| Tumor Cells, Cultured | 15 | 2021 | 6127 | 0.320 |
Why?
|
| Anemia, Aplastic | 1 | 2011 | 228 | 0.320 |
Why?
|
| Aged | 43 | 2024 | 168218 | 0.320 |
Why?
|
| Thrombosis | 2 | 2024 | 2929 | 0.310 |
Why?
|
| Genome, Human | 3 | 2020 | 4416 | 0.310 |
Why?
|
| Cryoelectron Microscopy | 2 | 2024 | 642 | 0.310 |
Why?
|
| Inflammation | 8 | 2023 | 10718 | 0.310 |
Why?
|
| Megakaryocytes | 7 | 2019 | 565 | 0.310 |
Why?
|
| RNA, Small Interfering | 9 | 2017 | 3432 | 0.310 |
Why?
|
| Cell Hypoxia | 10 | 2008 | 655 | 0.310 |
Why?
|
| Models, Biological | 11 | 2020 | 9460 | 0.310 |
Why?
|
| Mesenchymal Stem Cells | 4 | 2017 | 1634 | 0.310 |
Why?
|
| Aminopyridines | 3 | 2022 | 564 | 0.300 |
Why?
|
| Middle Aged | 48 | 2024 | 219568 | 0.300 |
Why?
|
| Open Reading Frames | 1 | 2011 | 814 | 0.300 |
Why?
|
| Janus Kinases | 4 | 2019 | 249 | 0.300 |
Why?
|
| DNA Modification Methylases | 2 | 2022 | 209 | 0.300 |
Why?
|
| Aortic Valve Stenosis | 1 | 2020 | 2002 | 0.290 |
Why?
|
| Neoplasm, Residual | 4 | 2022 | 1007 | 0.290 |
Why?
|
| Gene Dosage | 4 | 2017 | 1218 | 0.290 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 3 | 2021 | 305 | 0.290 |
Why?
|
| Oncogene Proteins, Fusion | 6 | 2020 | 1594 | 0.290 |
Why?
|
| Transplantation, Homologous | 4 | 2020 | 4809 | 0.290 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2018 | 1505 | 0.280 |
Why?
|
| Cell Lineage | 9 | 2017 | 2533 | 0.280 |
Why?
|
| Survival Analysis | 8 | 2020 | 10112 | 0.280 |
Why?
|
| Mice, Transgenic | 11 | 2024 | 9518 | 0.280 |
Why?
|
| Genes, p53 | 5 | 2022 | 712 | 0.280 |
Why?
|
| Telomerase | 1 | 2012 | 745 | 0.280 |
Why?
|
| Jurkat Cells | 2 | 2021 | 735 | 0.280 |
Why?
|
| Disease Susceptibility | 3 | 2023 | 1788 | 0.270 |
Why?
|
| DNA, Neoplasm | 1 | 2011 | 1745 | 0.270 |
Why?
|
| Transplantation Conditioning | 3 | 2020 | 1588 | 0.270 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2012 | 500 | 0.270 |
Why?
|
| Gene Silencing | 4 | 2014 | 1507 | 0.260 |
Why?
|
| Adult | 43 | 2024 | 219935 | 0.260 |
Why?
|
| Peptide Hydrolases | 3 | 2018 | 622 | 0.260 |
Why?
|
| Structure-Activity Relationship | 10 | 2024 | 3069 | 0.250 |
Why?
|
| Cell Proliferation | 14 | 2021 | 10416 | 0.250 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 4406 | 0.250 |
Why?
|
| RNA, Messenger | 9 | 2015 | 12759 | 0.250 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 3 | 2016 | 171 | 0.250 |
Why?
|
| Substrate Specificity | 3 | 2019 | 1792 | 0.250 |
Why?
|
| Interleukin-3 | 2 | 2022 | 425 | 0.240 |
Why?
|
| DNA Methylation | 4 | 2022 | 4373 | 0.240 |
Why?
|
| Genomic Instability | 3 | 2020 | 704 | 0.240 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2009 | 1055 | 0.240 |
Why?
|
| Loss of Heterozygosity | 4 | 2024 | 659 | 0.240 |
Why?
|
| Risk Factors | 20 | 2024 | 73809 | 0.240 |
Why?
|
| Leukemia, Myeloid | 3 | 2020 | 695 | 0.240 |
Why?
|
| Bone Marrow Transplantation | 5 | 2014 | 2693 | 0.240 |
Why?
|
| Cell Death | 3 | 2022 | 1668 | 0.240 |
Why?
|
| Drugs, Investigational | 2 | 2021 | 212 | 0.240 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2024 | 85 | 0.230 |
Why?
|
| Phthalimides | 1 | 2024 | 34 | 0.230 |
Why?
|
| Metabolic Diseases | 1 | 2011 | 682 | 0.230 |
Why?
|
| Apoptosis | 9 | 2023 | 9468 | 0.230 |
Why?
|
| Piperidones | 1 | 2024 | 37 | 0.230 |
Why?
|
| Receptors, AMPA | 8 | 1998 | 322 | 0.230 |
Why?
|
| Mevalonic Acid | 1 | 2024 | 46 | 0.230 |
Why?
|
| Mice, Inbred NOD | 5 | 2021 | 1825 | 0.230 |
Why?
|
| Molecular Sequence Data | 18 | 2015 | 17617 | 0.220 |
Why?
|
| Remission Induction | 3 | 2020 | 2388 | 0.220 |
Why?
|
| Cell Survival | 8 | 2020 | 5781 | 0.220 |
Why?
|
| Interleukin-7 | 1 | 2023 | 142 | 0.220 |
Why?
|
| Blood Platelet Disorders | 1 | 2023 | 60 | 0.220 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2023 | 2532 | 0.220 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 3 | 2023 | 350 | 0.220 |
Why?
|
| Flow Cytometry | 9 | 2016 | 5864 | 0.210 |
Why?
|
| Proteome | 4 | 2021 | 1855 | 0.210 |
Why?
|
| Biomedical Research | 1 | 2018 | 3418 | 0.210 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2021 | 3574 | 0.210 |
Why?
|
| Azacitidine | 3 | 2014 | 334 | 0.210 |
Why?
|
| Coronary Disease | 1 | 2017 | 5917 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 4 | 2023 | 1404 | 0.210 |
Why?
|
| Blood Physiological Phenomena | 1 | 2022 | 53 | 0.210 |
Why?
|
| Germ-Line Mutation | 5 | 2023 | 1840 | 0.210 |
Why?
|
| Macrophages | 5 | 2023 | 5737 | 0.210 |
Why?
|
| Genetic Linkage | 1 | 2008 | 2381 | 0.200 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2023 | 412 | 0.200 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 6 | 1 | 2021 | 27 | 0.200 |
Why?
|
| Allosteric Site | 1 | 2022 | 103 | 0.200 |
Why?
|
| Mosaicism | 2 | 2022 | 465 | 0.200 |
Why?
|
| Oncogenes | 2 | 2022 | 1220 | 0.200 |
Why?
|
| Gene Regulatory Networks | 1 | 2011 | 1740 | 0.200 |
Why?
|
| L-Lactate Dehydrogenase | 3 | 1998 | 410 | 0.200 |
Why?
|
| Protein Stability | 2 | 2022 | 566 | 0.200 |
Why?
|
| Interleukin-5 | 1 | 2022 | 269 | 0.200 |
Why?
|
| Cytarabine | 3 | 2019 | 696 | 0.200 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2003 | 155 | 0.200 |
Why?
|
| Ubiquitins | 1 | 2023 | 366 | 0.200 |
Why?
|
| Heart Failure | 3 | 2024 | 11593 | 0.200 |
Why?
|
| Mice, SCID | 4 | 2021 | 2626 | 0.190 |
Why?
|
| Septins | 1 | 2021 | 49 | 0.190 |
Why?
|
| Cytogenetic Analysis | 2 | 2013 | 270 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 4 | 2023 | 367 | 0.190 |
Why?
|
| Induced Pluripotent Stem Cells | 3 | 2023 | 1842 | 0.190 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 2 | 2020 | 184 | 0.190 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2022 | 117 | 0.190 |
Why?
|
| September 11 Terrorist Attacks | 1 | 2022 | 105 | 0.190 |
Why?
|
| Protein Binding | 8 | 2024 | 9311 | 0.190 |
Why?
|
| Models, Molecular | 4 | 2020 | 5410 | 0.190 |
Why?
|
| Histones | 4 | 2017 | 2577 | 0.190 |
Why?
|
| Quantitative Trait Loci | 2 | 2019 | 2100 | 0.190 |
Why?
|
| Hepatitis | 1 | 2023 | 229 | 0.190 |
Why?
|
| Mitochondria | 5 | 2019 | 3584 | 0.190 |
Why?
|
| Gene Expression Regulation, Leukemic | 4 | 2022 | 646 | 0.190 |
Why?
|
| Heme | 2 | 2013 | 313 | 0.190 |
Why?
|
| Cytokines | 6 | 2023 | 7338 | 0.190 |
Why?
|
| RNA Helicases | 2 | 2020 | 146 | 0.180 |
Why?
|
| Cell Line | 15 | 2022 | 15591 | 0.180 |
Why?
|
| Morpholines | 1 | 2024 | 580 | 0.180 |
Why?
|
| RNA-Binding Proteins | 3 | 2017 | 1894 | 0.180 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2021 | 213 | 0.180 |
Why?
|
| Lysine | 2 | 2017 | 998 | 0.180 |
Why?
|
| U937 Cells | 1 | 2021 | 262 | 0.180 |
Why?
|
| Welding | 1 | 2021 | 89 | 0.180 |
Why?
|
| Blood Cell Count | 1 | 2021 | 395 | 0.180 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2022 | 305 | 0.180 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2023 | 855 | 0.180 |
Why?
|
| Splenic Neoplasms | 1 | 2021 | 94 | 0.180 |
Why?
|
| Alendronate | 1 | 2021 | 172 | 0.180 |
Why?
|
| Carcinoma, Small Cell | 1 | 2003 | 416 | 0.180 |
Why?
|
| Homeodomain Proteins | 4 | 2019 | 2413 | 0.180 |
Why?
|
| Physicians | 1 | 2018 | 4580 | 0.180 |
Why?
|
| Dipeptides | 1 | 2022 | 386 | 0.180 |
Why?
|
| Aged, 80 and over | 19 | 2024 | 58683 | 0.180 |
Why?
|
| Young Adult | 17 | 2024 | 58808 | 0.170 |
Why?
|
| Oncogene Proteins | 2 | 2021 | 719 | 0.170 |
Why?
|
| Cells, Cultured | 15 | 2021 | 18940 | 0.170 |
Why?
|
| DNA Repair Enzymes | 1 | 2022 | 344 | 0.170 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 381 | 0.170 |
Why?
|
| Tissue Donors | 2 | 2020 | 2311 | 0.170 |
Why?
|
| Dacarbazine | 1 | 2003 | 559 | 0.170 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 8 | 1998 | 69 | 0.170 |
Why?
|
| Solvents | 1 | 2020 | 292 | 0.170 |
Why?
|
| Interleukin-1beta | 2 | 2022 | 996 | 0.170 |
Why?
|
| Anemia, Dyserythropoietic, Congenital | 1 | 2019 | 15 | 0.170 |
Why?
|
| Wills | 1 | 2019 | 13 | 0.170 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2021 | 178 | 0.170 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2020 | 234 | 0.170 |
Why?
|
| Menopause, Premature | 1 | 2020 | 124 | 0.170 |
Why?
|
| Polycyclic Compounds | 1 | 2019 | 29 | 0.170 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2020 | 11709 | 0.160 |
Why?
|
| Nephrotic Syndrome | 1 | 2003 | 391 | 0.160 |
Why?
|
| Enhancer Elements, Genetic | 6 | 1998 | 1356 | 0.160 |
Why?
|
| Lung Neoplasms | 6 | 2022 | 13245 | 0.160 |
Why?
|
| Genotype | 6 | 2021 | 12945 | 0.160 |
Why?
|
| Computational Biology | 3 | 2015 | 3502 | 0.160 |
Why?
|
| Mass Spectrometry | 3 | 2020 | 2189 | 0.160 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2022 | 886 | 0.160 |
Why?
|
| Ferritins | 1 | 2022 | 597 | 0.160 |
Why?
|
| Gene Expression | 6 | 2016 | 7583 | 0.160 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2003 | 617 | 0.160 |
Why?
|
| Disease Management | 3 | 2019 | 2500 | 0.160 |
Why?
|
| RNA, Neoplasm | 3 | 2020 | 749 | 0.160 |
Why?
|
| Air Pollutants, Occupational | 1 | 2021 | 407 | 0.160 |
Why?
|
| Synthetic Biology | 1 | 2020 | 185 | 0.150 |
Why?
|
| Serine | 1 | 2022 | 828 | 0.150 |
Why?
|
| Lactams | 1 | 2019 | 154 | 0.150 |
Why?
|
| Role | 1 | 2018 | 177 | 0.150 |
Why?
|
| Immunotherapy, Adoptive | 3 | 2024 | 1454 | 0.150 |
Why?
|
| Phthalazines | 1 | 2021 | 382 | 0.150 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2010 | 1136 | 0.150 |
Why?
|
| Myofibroblasts | 2 | 2017 | 207 | 0.150 |
Why?
|
| Chemokine CXCL12 | 1 | 2020 | 454 | 0.150 |
Why?
|
| GATA1 Transcription Factor | 1 | 2019 | 296 | 0.150 |
Why?
|
| Etoposide | 4 | 2019 | 630 | 0.150 |
Why?
|
| Duane Retraction Syndrome | 1 | 2018 | 59 | 0.150 |
Why?
|
| DNA Primers | 4 | 2014 | 2816 | 0.150 |
Why?
|
| Sequence Analysis, DNA | 5 | 2018 | 4711 | 0.150 |
Why?
|
| Osteoclasts | 1 | 2021 | 710 | 0.150 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2021 | 378 | 0.150 |
Why?
|
| Survival Rate | 6 | 2022 | 12721 | 0.150 |
Why?
|
| Receptors, GABA-A | 2 | 2001 | 621 | 0.150 |
Why?
|
| Immune System | 1 | 2023 | 796 | 0.150 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2018 | 198 | 0.150 |
Why?
|
| Blotting, Western | 4 | 2016 | 5031 | 0.150 |
Why?
|
| Hydrolases | 1 | 2018 | 146 | 0.140 |
Why?
|
| Monosaccharide Transport Proteins | 2 | 1996 | 436 | 0.140 |
Why?
|
| Hydrazones | 1 | 2017 | 102 | 0.140 |
Why?
|
| Disease Progression | 8 | 2023 | 13468 | 0.140 |
Why?
|
| Case-Control Studies | 6 | 2022 | 22029 | 0.140 |
Why?
|
| Zygote | 1 | 2017 | 115 | 0.140 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2017 | 69 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 3 | 2015 | 6068 | 0.140 |
Why?
|
| Stem Cells | 4 | 2023 | 3521 | 0.140 |
Why?
|
| Alternative Splicing | 2 | 2019 | 1090 | 0.140 |
Why?
|
| Excitatory Amino Acid Agonists | 4 | 1998 | 143 | 0.140 |
Why?
|
| Stromal Cells | 3 | 2011 | 1326 | 0.140 |
Why?
|
| Colony-Forming Units Assay | 5 | 2020 | 351 | 0.140 |
Why?
|
| Interleukins | 1 | 2021 | 783 | 0.140 |
Why?
|
| Genes, Dominant | 1 | 2019 | 862 | 0.140 |
Why?
|
| Immunity, Innate | 4 | 2023 | 3047 | 0.140 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2023 | 695 | 0.140 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2019 | 316 | 0.140 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2019 | 15773 | 0.130 |
Why?
|
| DNA Helicases | 2 | 2020 | 854 | 0.130 |
Why?
|
| Neutropenia | 1 | 2021 | 884 | 0.130 |
Why?
|
| Species Specificity | 3 | 2018 | 2417 | 0.130 |
Why?
|
| Uric Acid | 1 | 2022 | 803 | 0.130 |
Why?
|
| Alanine | 3 | 1998 | 603 | 0.130 |
Why?
|
| Histone Demethylases | 1 | 2019 | 319 | 0.130 |
Why?
|
| Introns | 1 | 2019 | 978 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 3 | 2016 | 1610 | 0.130 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 7 | 2006 | 611 | 0.130 |
Why?
|
| Germ Cells | 1 | 2020 | 635 | 0.130 |
Why?
|
| Mice, Inbred BALB C | 5 | 2012 | 6209 | 0.130 |
Why?
|
| Disasters | 1 | 2022 | 517 | 0.130 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2019 | 545 | 0.130 |
Why?
|
| Gene Knockout Techniques | 2 | 2016 | 802 | 0.130 |
Why?
|
| Treatment Outcome | 11 | 2020 | 64378 | 0.130 |
Why?
|
| Receptors, CXCR4 | 1 | 2020 | 727 | 0.130 |
Why?
|
| Ribonucleoprotein, U2 Small Nuclear | 1 | 2014 | 21 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2018 | 345 | 0.120 |
Why?
|
| Tissue Banks | 1 | 2016 | 184 | 0.120 |
Why?
|
| Lentivirus | 2 | 2015 | 503 | 0.120 |
Why?
|
| Eosinophilia | 1 | 2020 | 559 | 0.120 |
Why?
|
| GTP-Binding Protein beta Subunits | 1 | 2014 | 33 | 0.120 |
Why?
|
| Myocytes, Cardiac | 1 | 2024 | 1655 | 0.120 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2016 | 714 | 0.120 |
Why?
|
| Genome | 3 | 2023 | 1739 | 0.120 |
Why?
|
| Ubiquitin | 1 | 2020 | 837 | 0.120 |
Why?
|
| Methylation | 1 | 2017 | 1080 | 0.120 |
Why?
|
| beta-Globins | 1 | 2015 | 108 | 0.120 |
Why?
|
| Myeloid Progenitor Cells | 2 | 2017 | 113 | 0.120 |
Why?
|
| Protein Conformation | 2 | 2022 | 3966 | 0.120 |
Why?
|
| Mutagenesis, Insertional | 1 | 2017 | 652 | 0.120 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2015 | 251 | 0.120 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2003 | 5246 | 0.120 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2016 | 2470 | 0.120 |
Why?
|
| Antigens, Nuclear | 1 | 2014 | 184 | 0.120 |
Why?
|
| Histocompatibility Antigens | 1 | 2015 | 467 | 0.120 |
Why?
|
| Ribosomal Protein S6 | 1 | 2014 | 71 | 0.120 |
Why?
|
| Genes, ras | 1 | 2017 | 654 | 0.120 |
Why?
|
| Protein Biosynthesis | 3 | 2012 | 2105 | 0.110 |
Why?
|
| Africa | 2 | 2020 | 706 | 0.110 |
Why?
|
| Protein Multimerization | 2 | 2024 | 979 | 0.110 |
Why?
|
| Heart Arrest | 1 | 2024 | 1494 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2014 | 358 | 0.110 |
Why?
|
| HeLa Cells | 8 | 2020 | 3096 | 0.110 |
Why?
|
| Age of Onset | 1 | 2020 | 3298 | 0.110 |
Why?
|
| Neoplasms, Experimental | 1 | 2019 | 1228 | 0.110 |
Why?
|
| Microscopy, Confocal | 3 | 2016 | 1969 | 0.110 |
Why?
|
| Cancer Vaccines | 1 | 2021 | 1046 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 989 | 0.110 |
Why?
|
| GABA-A Receptor Agonists | 1 | 2013 | 86 | 0.110 |
Why?
|
| Amino Acid Sequence | 5 | 2018 | 13447 | 0.110 |
Why?
|
| Benzothiazoles | 2 | 2012 | 246 | 0.110 |
Why?
|
| Oxygen | 7 | 2008 | 4191 | 0.110 |
Why?
|
| GTP-Binding Proteins | 2 | 2014 | 950 | 0.110 |
Why?
|
| Tumor Microenvironment | 2 | 2019 | 3840 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 5 | 2019 | 5779 | 0.110 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 1 | 2015 | 179 | 0.110 |
Why?
|
| Nitriles | 1 | 2018 | 957 | 0.110 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2013 | 81 | 0.110 |
Why?
|
| Adolescent | 13 | 2024 | 87892 | 0.100 |
Why?
|
| Communicable Diseases | 1 | 2021 | 877 | 0.100 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 2 | 2024 | 263 | 0.100 |
Why?
|
| Thiazoles | 3 | 2014 | 1510 | 0.100 |
Why?
|
| Recurrence | 3 | 2022 | 8426 | 0.100 |
Why?
|
| Mastocytosis, Systemic | 1 | 2014 | 102 | 0.100 |
Why?
|
| Liver Cirrhosis | 1 | 2023 | 1930 | 0.100 |
Why?
|
| Hematocrit | 2 | 2013 | 627 | 0.100 |
Why?
|
| DNA Copy Number Variations | 3 | 2024 | 2012 | 0.100 |
Why?
|
| Syndrome | 2 | 2010 | 3262 | 0.100 |
Why?
|
| alpha-Globins | 1 | 2012 | 19 | 0.100 |
Why?
|
| History, 21st Century | 1 | 2018 | 1573 | 0.100 |
Why?
|
| Gene Frequency | 2 | 2020 | 3612 | 0.100 |
Why?
|
| Isoenzymes | 2 | 1996 | 1686 | 0.100 |
Why?
|
| Coronary Artery Disease | 2 | 2022 | 6362 | 0.100 |
Why?
|
| Hypoxia-Inducible Factor 1 | 6 | 1998 | 192 | 0.100 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 1931 | 0.100 |
Why?
|
| Transplantation Chimera | 1 | 2014 | 595 | 0.100 |
Why?
|
| Up-Regulation | 3 | 2012 | 4113 | 0.100 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2014 | 503 | 0.100 |
Why?
|
| Leukocytes | 1 | 2020 | 2025 | 0.100 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2016 | 730 | 0.100 |
Why?
|
| Receptors, GABA | 1 | 2013 | 305 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2022 | 2800 | 0.100 |
Why?
|
| Phosphorylation | 6 | 2014 | 8297 | 0.100 |
Why?
|
| Postmenopause | 1 | 2020 | 2509 | 0.100 |
Why?
|
| Medical Oncology | 2 | 2020 | 2312 | 0.100 |
Why?
|
| Pimozide | 1 | 2011 | 21 | 0.100 |
Why?
|
| Genome-Wide Association Study | 6 | 2021 | 12604 | 0.090 |
Why?
|
| Glutarates | 1 | 2013 | 244 | 0.090 |
Why?
|
| B-Lymphocytes | 2 | 2019 | 4738 | 0.090 |
Why?
|
| Toluene | 1 | 2010 | 32 | 0.090 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2011 | 104 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 4 | 2016 | 2057 | 0.090 |
Why?
|
| Gene Targeting | 1 | 2014 | 837 | 0.090 |
Why?
|
| Pyrazoles | 2 | 2019 | 1988 | 0.090 |
Why?
|
| Sequence Alignment | 1 | 2015 | 2176 | 0.090 |
Why?
|
| Zebrafish Proteins | 2 | 2014 | 1006 | 0.090 |
Why?
|
| Response Elements | 2 | 2010 | 308 | 0.090 |
Why?
|
| Megakaryocyte-Erythroid Progenitor Cells | 1 | 2010 | 10 | 0.090 |
Why?
|
| Occupational Exposure | 1 | 2021 | 1809 | 0.090 |
Why?
|
| Neoplasm Transplantation | 5 | 2016 | 2013 | 0.090 |
Why?
|
| Genetic Vectors | 3 | 2017 | 3380 | 0.090 |
Why?
|
| Megakaryocyte Progenitor Cells | 1 | 2010 | 28 | 0.090 |
Why?
|
| beta-Thalassemia | 1 | 2013 | 235 | 0.090 |
Why?
|
| Hemoglobins | 2 | 2013 | 1519 | 0.090 |
Why?
|
| History, 20th Century | 1 | 2018 | 2772 | 0.090 |
Why?
|
| Treatment Failure | 2 | 2014 | 2640 | 0.090 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 2 | 2019 | 495 | 0.090 |
Why?
|
| Iron Regulatory Protein 1 | 1 | 2010 | 37 | 0.090 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2021 | 2115 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2014 | 726 | 0.090 |
Why?
|
| Cell Nucleolus | 1 | 2010 | 156 | 0.090 |
Why?
|
| Uniparental Disomy | 1 | 2010 | 45 | 0.090 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2010 | 151 | 0.090 |
Why?
|
| STAT5 Transcription Factor | 1 | 2011 | 263 | 0.090 |
Why?
|
| Prostaglandin D2 | 1 | 2010 | 108 | 0.090 |
Why?
|
| Cobalt | 5 | 1996 | 154 | 0.090 |
Why?
|
| Hospitals | 1 | 2023 | 3887 | 0.090 |
Why?
|
| Tissue Scaffolds | 2 | 2016 | 926 | 0.090 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2016 | 2504 | 0.090 |
Why?
|
| GTP Phosphohydrolases | 1 | 2013 | 517 | 0.090 |
Why?
|
| Antigens, CD | 2 | 2010 | 3997 | 0.090 |
Why?
|
| Toll-Like Receptors | 1 | 2013 | 590 | 0.080 |
Why?
|
| Binding Sites | 4 | 2024 | 6036 | 0.080 |
Why?
|
| Pneumonia | 1 | 2021 | 2129 | 0.080 |
Why?
|
| Cytoplasmic Granules | 1 | 2012 | 573 | 0.080 |
Why?
|
| Sulfonamides | 3 | 2022 | 1973 | 0.080 |
Why?
|
| Transfection | 6 | 2019 | 5779 | 0.080 |
Why?
|
| Drosophila melanogaster | 2 | 2015 | 1710 | 0.080 |
Why?
|
| Piperidines | 2 | 2019 | 1639 | 0.080 |
Why?
|
| Interleukin-2 | 2 | 2013 | 1888 | 0.080 |
Why?
|
| Risk | 2 | 2021 | 9599 | 0.080 |
Why?
|
| Organ Specificity | 4 | 2015 | 1955 | 0.080 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2010 | 180 | 0.080 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2008 | 18 | 0.080 |
Why?
|
| World Health Organization | 3 | 2022 | 1312 | 0.080 |
Why?
|
| Drug Discovery | 1 | 2017 | 1044 | 0.080 |
Why?
|
| Vitamins | 1 | 2017 | 1632 | 0.080 |
Why?
|
| Follow-Up Studies | 5 | 2022 | 39059 | 0.080 |
Why?
|
| Immunologic Factors | 2 | 2015 | 1585 | 0.080 |
Why?
|
| Mitoxantrone | 2 | 2019 | 148 | 0.080 |
Why?
|
| Interferon-alpha | 1 | 2013 | 918 | 0.080 |
Why?
|
| Trans-Activators | 1 | 1998 | 2860 | 0.080 |
Why?
|
| Deferoxamine | 4 | 1996 | 153 | 0.080 |
Why?
|
| Pyrrolidines | 1 | 2010 | 337 | 0.080 |
Why?
|
| Luciferases | 2 | 2012 | 714 | 0.080 |
Why?
|
| Cell Division | 2 | 2014 | 4458 | 0.080 |
Why?
|
| Health Status | 1 | 2021 | 4071 | 0.080 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2016 | 462 | 0.080 |
Why?
|
| NF-kappa B | 3 | 2018 | 2472 | 0.080 |
Why?
|
| RNA, Ribosomal, 18S | 1 | 2008 | 57 | 0.080 |
Why?
|
| beta Catenin | 1 | 2013 | 1043 | 0.080 |
Why?
|
| Lymphoma, B-Cell | 1 | 2014 | 935 | 0.080 |
Why?
|
| Stereoisomerism | 7 | 1999 | 613 | 0.070 |
Why?
|
| Prevalence | 3 | 2021 | 15651 | 0.070 |
Why?
|
| Fibrosis | 1 | 2014 | 2038 | 0.070 |
Why?
|
| Lipids | 1 | 2018 | 3326 | 0.070 |
Why?
|
| Molecular Structure | 6 | 2024 | 1866 | 0.070 |
Why?
|
| 5' Untranslated Regions | 1 | 2008 | 256 | 0.070 |
Why?
|
| Embryonic Development | 1 | 2012 | 716 | 0.070 |
Why?
|
| Fatal Outcome | 1 | 2012 | 1829 | 0.070 |
Why?
|
| Casein Kinase II | 1 | 2007 | 122 | 0.070 |
Why?
|
| Coculture Techniques | 1 | 2011 | 1339 | 0.070 |
Why?
|
| Drug Approval | 1 | 2014 | 808 | 0.070 |
Why?
|
| Sepsis | 1 | 2021 | 2587 | 0.070 |
Why?
|
| Rats | 16 | 2019 | 23679 | 0.070 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2020 | 3071 | 0.070 |
Why?
|
| RNA, Ribosomal | 1 | 2008 | 226 | 0.070 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 3216 | 0.070 |
Why?
|
| Glioma | 1 | 2022 | 3418 | 0.070 |
Why?
|
| Pluripotent Stem Cells | 1 | 2013 | 792 | 0.070 |
Why?
|
| Prospective Studies | 6 | 2024 | 54137 | 0.070 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2013 | 929 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 4567 | 0.070 |
Why?
|
| Mitochondrial Proteins | 1 | 2012 | 977 | 0.070 |
Why?
|
| Spleen | 2 | 2010 | 2296 | 0.070 |
Why?
|
| Hyperglycemia | 1 | 2015 | 1368 | 0.070 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2007 | 159 | 0.070 |
Why?
|
| Cell Count | 1 | 2010 | 1835 | 0.070 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2011 | 685 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2010 | 4549 | 0.060 |
Why?
|
| Heterozygote | 2 | 2010 | 2797 | 0.060 |
Why?
|
| Tissue Engineering | 1 | 2016 | 1870 | 0.060 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 2 | 2023 | 367 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2010 | 1694 | 0.060 |
Why?
|
| Predictive Value of Tests | 3 | 2012 | 15225 | 0.060 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2008 | 627 | 0.060 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 1134 | 0.060 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 3 | 1999 | 788 | 0.060 |
Why?
|
| Drug Therapy, Combination | 2 | 2014 | 6293 | 0.060 |
Why?
|
| Homeostasis | 2 | 2014 | 3301 | 0.060 |
Why?
|
| Proline | 1 | 2006 | 456 | 0.060 |
Why?
|
| Energy Metabolism | 1 | 1996 | 2868 | 0.060 |
Why?
|
| Chromosome Mapping | 1 | 2013 | 4624 | 0.060 |
Why?
|
| Stem Cell Factor | 1 | 2005 | 195 | 0.060 |
Why?
|
| Imidazoles | 1 | 2010 | 1179 | 0.060 |
Why?
|
| Piperazines | 2 | 2016 | 2511 | 0.060 |
Why?
|
| Algorithms | 2 | 2019 | 13961 | 0.060 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 1996 | 892 | 0.060 |
Why?
|
| RNA | 1 | 2014 | 2716 | 0.060 |
Why?
|
| Genetic Testing | 2 | 2016 | 3530 | 0.060 |
Why?
|
| Circadian Rhythm | 1 | 2016 | 2567 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2024 | 10748 | 0.060 |
Why?
|
| Translocation, Genetic | 1 | 2010 | 1387 | 0.060 |
Why?
|
| Pedigree | 1 | 2012 | 4578 | 0.060 |
Why?
|
| Protoporphyrins | 2 | 2003 | 165 | 0.060 |
Why?
|
| Genetic Complementation Test | 2 | 2017 | 555 | 0.060 |
Why?
|
| Thrombocythemia, Essential | 1 | 2005 | 106 | 0.060 |
Why?
|
| Synapses | 1 | 2013 | 1757 | 0.060 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 6821 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6493 | 0.060 |
Why?
|
| Child | 7 | 2023 | 79818 | 0.060 |
Why?
|
| Risk Assessment | 3 | 2022 | 23884 | 0.060 |
Why?
|
| Acetates | 2 | 1996 | 321 | 0.060 |
Why?
|
| Cell Line, Transformed | 1 | 2005 | 869 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2021 | 2872 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 1651 | 0.060 |
Why?
|
| Dimerization | 2 | 2019 | 888 | 0.060 |
Why?
|
| Diet | 1 | 2021 | 8005 | 0.050 |
Why?
|
| HIV | 1 | 2010 | 1581 | 0.050 |
Why?
|
| Glucose | 1 | 2015 | 4336 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2015 | 3299 | 0.050 |
Why?
|
| Reproducibility of Results | 4 | 2018 | 20055 | 0.050 |
Why?
|
| Esophagus | 2 | 2014 | 1023 | 0.050 |
Why?
|
| Frameshift Mutation | 2 | 2019 | 388 | 0.050 |
Why?
|
| Diagnosis, Differential | 3 | 2015 | 12951 | 0.050 |
Why?
|
| Single-Cell Analysis | 3 | 2021 | 2379 | 0.050 |
Why?
|
| Azepines | 1 | 2024 | 329 | 0.050 |
Why?
|
| Proportional Hazards Models | 2 | 2021 | 12440 | 0.050 |
Why?
|
| Retroviridae | 1 | 2005 | 850 | 0.050 |
Why?
|
| Bradycardia | 1 | 2024 | 299 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2011 | 2904 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 11070 | 0.050 |
Why?
|
| Tetraploidy | 1 | 2021 | 28 | 0.050 |
Why?
|
| Proteoglycans | 2 | 2016 | 801 | 0.050 |
Why?
|
| Stem Cell Transplantation | 2 | 2023 | 1599 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 2012 | 4938 | 0.050 |
Why?
|
| Immunologic Memory | 1 | 2008 | 1353 | 0.050 |
Why?
|
| Genetic Markers | 1 | 2008 | 2608 | 0.050 |
Why?
|
| Infant | 4 | 2022 | 36055 | 0.050 |
Why?
|
| Cluster Analysis | 3 | 2015 | 2697 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2003 | 8981 | 0.050 |
Why?
|
| Genes, Overlapping | 1 | 2021 | 36 | 0.050 |
Why?
|
| Caspases, Initiator | 1 | 2021 | 31 | 0.050 |
Why?
|
| GABA Antagonists | 1 | 2001 | 120 | 0.050 |
Why?
|
| Age Factors | 2 | 2015 | 18358 | 0.050 |
Why?
|
| GABA Agonists | 1 | 2001 | 105 | 0.050 |
Why?
|
| alpha Karyopherins | 1 | 2020 | 40 | 0.050 |
Why?
|
| Homozygote | 3 | 2014 | 1788 | 0.050 |
Why?
|
| Carbocyanines | 1 | 2001 | 175 | 0.050 |
Why?
|
| Fusion Proteins, bcr-abl | 2 | 2014 | 431 | 0.050 |
Why?
|
| Fanconi Anemia Complementation Group A Protein | 1 | 2020 | 50 | 0.050 |
Why?
|
| Genetic Association Studies | 1 | 2010 | 2717 | 0.040 |
Why?
|
| Gases | 1 | 2021 | 203 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2011 | 4087 | 0.040 |
Why?
|
| Proteinuria | 1 | 2003 | 594 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2010 | 1793 | 0.040 |
Why?
|
| North America | 1 | 2024 | 1276 | 0.040 |
Why?
|
| Iron | 1 | 2008 | 1786 | 0.040 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2021 | 93 | 0.040 |
Why?
|
| Caspase 1 | 1 | 2021 | 226 | 0.040 |
Why?
|
| Consensus | 2 | 2022 | 3099 | 0.040 |
Why?
|
| Odds Ratio | 2 | 2023 | 9650 | 0.040 |
Why?
|
| Zebrafish | 3 | 2020 | 2993 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2014 | 11152 | 0.040 |
Why?
|
| Calmodulin | 1 | 2020 | 217 | 0.040 |
Why?
|
| Brain Stem Neoplasms | 1 | 2022 | 190 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2008 | 1885 | 0.040 |
Why?
|
| Pentanoic Acids | 1 | 1999 | 17 | 0.040 |
Why?
|
| Molecular Biology | 1 | 2023 | 580 | 0.040 |
Why?
|
| Digestive System Diseases | 1 | 2021 | 151 | 0.040 |
Why?
|
| Logistic Models | 1 | 2014 | 13276 | 0.040 |
Why?
|
| Genetic Fitness | 1 | 2020 | 115 | 0.040 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2021 | 298 | 0.040 |
Why?
|
| GABA Agents | 1 | 1999 | 41 | 0.040 |
Why?
|
| Genes, Reporter | 2 | 2017 | 1527 | 0.040 |
Why?
|
| Dizocilpine Maleate | 3 | 1994 | 172 | 0.040 |
Why?
|
| Bone and Bones | 1 | 2010 | 2560 | 0.040 |
Why?
|
| Troponin T | 1 | 2024 | 761 | 0.040 |
Why?
|
| Xenopus | 1 | 2001 | 717 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2008 | 1171 | 0.040 |
Why?
|
| Dust | 1 | 2022 | 486 | 0.040 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2020 | 321 | 0.040 |
Why?
|
| Triazoles | 1 | 2024 | 902 | 0.040 |
Why?
|
| Lower Extremity Deformities, Congenital | 1 | 2018 | 12 | 0.040 |
Why?
|
| Crystallography, X-Ray | 4 | 1998 | 1974 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2019 | 8530 | 0.040 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 1998 | 448 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 12096 | 0.040 |
Why?
|
| Activating Transcription Factor 1 | 1 | 1998 | 26 | 0.040 |
Why?
|
| Barrett Esophagus | 1 | 2003 | 490 | 0.040 |
Why?
|
| Mutant Proteins | 2 | 2013 | 491 | 0.040 |
Why?
|
| Enzyme Activation | 3 | 2012 | 3593 | 0.040 |
Why?
|
| Baclofen | 1 | 1999 | 120 | 0.040 |
Why?
|
| Polycythemia | 1 | 1999 | 125 | 0.040 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2019 | 99 | 0.040 |
Why?
|
| Child, Preschool | 5 | 2022 | 42062 | 0.040 |
Why?
|
| Models, Genetic | 2 | 2007 | 3441 | 0.040 |
Why?
|
| Upper Extremity Deformities, Congenital | 1 | 2018 | 32 | 0.040 |
Why?
|
| Inhalation Exposure | 1 | 2021 | 429 | 0.040 |
Why?
|
| Phosphoglycerate Kinase | 2 | 1996 | 66 | 0.040 |
Why?
|
| Receptors, Metabotropic Glutamate | 2 | 1998 | 195 | 0.040 |
Why?
|
| Retrospective Studies | 6 | 2024 | 80168 | 0.040 |
Why?
|
| Urogenital Abnormalities | 1 | 2021 | 256 | 0.040 |
Why?
|
| Calcium Chloride | 1 | 1998 | 78 | 0.040 |
Why?
|
| Myeloid Cells | 2 | 2018 | 820 | 0.040 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2019 | 158 | 0.040 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2020 | 331 | 0.040 |
Why?
|
| CREB-Binding Protein | 1 | 1998 | 148 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2019 | 372 | 0.040 |
Why?
|
| Caspase 8 | 1 | 2018 | 189 | 0.040 |
Why?
|
| Teratogens | 1 | 2018 | 117 | 0.040 |
Why?
|
| Kainic Acid | 2 | 1997 | 198 | 0.040 |
Why?
|
| RNA Splice Sites | 1 | 2019 | 211 | 0.040 |
Why?
|
| Japan | 1 | 2022 | 1366 | 0.040 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2019 | 241 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2001 | 942 | 0.040 |
Why?
|
| Allyl Compounds | 1 | 2017 | 22 | 0.040 |
Why?
|
| Aortic Diseases | 1 | 2023 | 735 | 0.040 |
Why?
|
| HIV Infections | 1 | 2024 | 17275 | 0.040 |
Why?
|
| Receptors, Glutamate | 1 | 1998 | 228 | 0.040 |
Why?
|
| Granulocytes | 2 | 2012 | 550 | 0.040 |
Why?
|
| Leukemia, Biphenotypic, Acute | 1 | 2017 | 32 | 0.040 |
Why?
|
| Mice, Nude | 3 | 2012 | 3602 | 0.040 |
Why?
|
| Furans | 1 | 1998 | 199 | 0.040 |
Why?
|
| Karyotyping | 1 | 2019 | 1171 | 0.030 |
Why?
|
| Granulocyte Precursor Cells | 1 | 2016 | 49 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2019 | 629 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 2 | 2015 | 2001 | 0.030 |
Why?
|
| Gene Rearrangement | 1 | 2022 | 1122 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2020 | 1972 | 0.030 |
Why?
|
| Benzimidazoles | 1 | 2022 | 855 | 0.030 |
Why?
|
| Kinetics | 2 | 2021 | 6371 | 0.030 |
Why?
|
| Demography | 1 | 2021 | 1651 | 0.030 |
Why?
|
| DNA | 2 | 2023 | 7199 | 0.030 |
Why?
|
| Oocytes | 1 | 2001 | 1165 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2013 | 7843 | 0.030 |
Why?
|
| Rotenone | 1 | 1995 | 45 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1613 | 0.030 |
Why?
|
| Glycine | 3 | 1994 | 662 | 0.030 |
Why?
|
| Onium Compounds | 1 | 1995 | 27 | 0.030 |
Why?
|
| Delayed Diagnosis | 1 | 2020 | 463 | 0.030 |
Why?
|
| Globins | 1 | 2017 | 403 | 0.030 |
Why?
|
| Infant, Newborn | 3 | 2021 | 26183 | 0.030 |
Why?
|
| Ibotenic Acid | 2 | 1992 | 59 | 0.030 |
Why?
|
| Arecoline | 1 | 1995 | 9 | 0.030 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2001 | 739 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2005 | 2416 | 0.030 |
Why?
|
| Sensitivity and Specificity | 4 | 2020 | 14641 | 0.030 |
Why?
|
| Hemolymph | 1 | 2015 | 27 | 0.030 |
Why?
|
| Siderophores | 1 | 1996 | 61 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1996 | 416 | 0.030 |
Why?
|
| Nucleic Acid Denaturation | 1 | 2015 | 110 | 0.030 |
Why?
|
| Fat Body | 1 | 2015 | 31 | 0.030 |
Why?
|
| Mammography | 1 | 2006 | 2427 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 782 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2020 | 1083 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2005 | 2144 | 0.030 |
Why?
|
| Glucose Transporter Type 1 | 1 | 1995 | 186 | 0.030 |
Why?
|
| Blood Vessels | 2 | 2014 | 1112 | 0.030 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2018 | 460 | 0.030 |
Why?
|
| Maximum Tolerated Dose | 1 | 2017 | 876 | 0.030 |
Why?
|
| Muscarinic Agonists | 1 | 1995 | 91 | 0.030 |
Why?
|
| Smoking | 2 | 2022 | 9051 | 0.030 |
Why?
|
| Melanoma | 1 | 2013 | 5691 | 0.030 |
Why?
|
| Brain | 7 | 2013 | 26947 | 0.030 |
Why?
|
| Trehalose | 1 | 2015 | 88 | 0.030 |
Why?
|
| Birth Weight | 1 | 2023 | 2097 | 0.030 |
Why?
|
| Calcium Phosphates | 1 | 2016 | 171 | 0.030 |
Why?
|
| Breast Neoplasms | 3 | 2020 | 21017 | 0.030 |
Why?
|
| Incidence | 2 | 2024 | 21272 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2024 | 41256 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1995 | 818 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2023 | 1878 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 2001 | 1539 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2021 | 1826 | 0.030 |
Why?
|
| Isoquinolines | 1 | 2016 | 352 | 0.030 |
Why?
|
| Electrophysiology | 4 | 1998 | 1263 | 0.030 |
Why?
|
| Laminin | 1 | 2016 | 405 | 0.030 |
Why?
|
| Hospitalization | 1 | 2014 | 10652 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 723 | 0.030 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 223 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2024 | 3208 | 0.030 |
Why?
|
| Carbohydrate Metabolism | 1 | 2015 | 262 | 0.030 |
Why?
|
| Multipotent Stem Cells | 1 | 2015 | 200 | 0.030 |
Why?
|
| Heterocyclic Compounds | 1 | 1995 | 246 | 0.030 |
Why?
|
| Binding, Competitive | 4 | 1999 | 1141 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2019 | 1076 | 0.030 |
Why?
|
| Drug Partial Agonism | 1 | 2013 | 24 | 0.030 |
Why?
|
| Diphtheria Toxin | 1 | 2014 | 252 | 0.030 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2008 | 2420 | 0.030 |
Why?
|
| Genes, Neurofibromatosis 2 | 1 | 2013 | 122 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2001 | 2646 | 0.030 |
Why?
|
| Toll-Like Receptor 6 | 1 | 2013 | 29 | 0.030 |
Why?
|
| Chelating Agents | 1 | 1995 | 383 | 0.030 |
Why?
|
| Toll-Like Receptor 1 | 1 | 2013 | 48 | 0.030 |
Why?
|
| raf Kinases | 1 | 2013 | 118 | 0.030 |
Why?
|
| Lovastatin | 1 | 2013 | 116 | 0.030 |
Why?
|
| Mediator Complex | 1 | 2013 | 106 | 0.030 |
Why?
|
| Clodronic Acid | 1 | 2013 | 59 | 0.030 |
Why?
|
| Adenine | 1 | 2019 | 975 | 0.030 |
Why?
|
| Gene Order | 1 | 2013 | 169 | 0.030 |
Why?
|
| Calreticulin | 1 | 2014 | 114 | 0.030 |
Why?
|
| Antigens, Neoplasm | 1 | 2021 | 1997 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2001 | 1897 | 0.030 |
Why?
|
| Cerebral Cortex | 5 | 1997 | 5759 | 0.030 |
Why?
|
| Receptors, Amino Acid | 1 | 1992 | 30 | 0.030 |
Why?
|
| Growth Substances | 1 | 1995 | 768 | 0.030 |
Why?
|
| Ferrochelatase | 1 | 2012 | 47 | 0.030 |
Why?
|
| Erythrocyte Count | 1 | 2013 | 157 | 0.030 |
Why?
|
| Cullin Proteins | 1 | 2013 | 178 | 0.030 |
Why?
|
| Antibodies | 1 | 2021 | 2420 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2019 | 2209 | 0.030 |
Why?
|
| Tyrphostins | 1 | 2012 | 63 | 0.030 |
Why?
|
| TYK2 Kinase | 1 | 2012 | 37 | 0.030 |
Why?
|
| Receptors, Kainic Acid | 3 | 1997 | 89 | 0.030 |
Why?
|
| Corpus Callosum | 1 | 1997 | 749 | 0.030 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2016 | 623 | 0.030 |
Why?
|
| Esophageal Neoplasms | 1 | 2003 | 1648 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2016 | 2557 | 0.030 |
Why?
|
| Janus Kinase 1 | 1 | 2012 | 107 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1995 | 1693 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2024 | 3812 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 2129 | 0.030 |
Why?
|
| Reticulocytes | 1 | 2013 | 288 | 0.030 |
Why?
|
| Blast Crisis | 1 | 2012 | 101 | 0.020 |
Why?
|
| Streptococcus pyogenes | 1 | 2014 | 294 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2024 | 4429 | 0.020 |
Why?
|
| Pericytes | 1 | 2014 | 293 | 0.020 |
Why?
|
| Anemia, Sideroblastic | 1 | 2012 | 109 | 0.020 |
Why?
|
| Glycolysis | 1 | 1996 | 826 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2016 | 1871 | 0.020 |
Why?
|
| Acute Disease | 1 | 2022 | 7225 | 0.020 |
Why?
|
| Echocardiography | 1 | 2024 | 4962 | 0.020 |
Why?
|
| Random Allocation | 1 | 2016 | 2385 | 0.020 |
Why?
|
| Phenylalanine | 1 | 2013 | 365 | 0.020 |
Why?
|
| eIF-2 Kinase | 1 | 2012 | 144 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 877 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 507 | 0.020 |
Why?
|
| N-Methylaspartate | 3 | 1997 | 231 | 0.020 |
Why?
|
| Molecular Conformation | 3 | 1998 | 543 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 1997 | 1167 | 0.020 |
Why?
|
| Valine | 1 | 2013 | 408 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2013 | 346 | 0.020 |
Why?
|
| Gastric Mucosa | 1 | 2014 | 600 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2018 | 1262 | 0.020 |
Why?
|
| Recombination, Genetic | 2 | 2006 | 1526 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 2017 | 1268 | 0.020 |
Why?
|
| Women's Health | 1 | 2020 | 2057 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 2018 | 1414 | 0.020 |
Why?
|
| Gene Library | 1 | 2013 | 1059 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2014 | 746 | 0.020 |
Why?
|
| Serpins | 1 | 2012 | 247 | 0.020 |
Why?
|
| Biphenyl Compounds | 1 | 1995 | 988 | 0.020 |
Why?
|
| Sex Factors | 1 | 2024 | 10504 | 0.020 |
Why?
|
| Time Factors | 3 | 2013 | 39872 | 0.020 |
Why?
|
| Tomography | 1 | 2012 | 411 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2013 | 1094 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 857 | 0.020 |
Why?
|
| Muscles | 1 | 2015 | 1579 | 0.020 |
Why?
|
| Propionates | 1 | 1991 | 182 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2013 | 696 | 0.020 |
Why?
|
| International Cooperation | 1 | 2016 | 1430 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2013 | 8143 | 0.020 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 2010 | 139 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 1705 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2016 | 3090 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2021 | 2723 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2016 | 2020 | 0.020 |
Why?
|
| Sarcoma, Myeloid | 1 | 2010 | 51 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2019 | 2413 | 0.020 |
Why?
|
| Stomach | 1 | 2014 | 694 | 0.020 |
Why?
|
| Codon, Terminator | 1 | 2010 | 125 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2003 | 681 | 0.020 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2012 | 423 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 8945 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 2013 | 965 | 0.020 |
Why?
|
| Hematinics | 1 | 2012 | 280 | 0.020 |
Why?
|
| Endothelial Cells | 2 | 2014 | 3533 | 0.020 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2008 | 21 | 0.020 |
Why?
|
| Iron-Regulatory Proteins | 1 | 2008 | 30 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2020 | 3099 | 0.020 |
Why?
|
| Antigens | 1 | 2014 | 1445 | 0.020 |
Why?
|
| Osteogenesis | 1 | 2016 | 1271 | 0.020 |
Why?
|
| Autophagy | 1 | 2017 | 1322 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2012 | 900 | 0.020 |
Why?
|
| Vaccination | 1 | 2021 | 3355 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2016 | 4839 | 0.020 |
Why?
|
| Platelet Membrane Glycoprotein IIb | 1 | 2008 | 51 | 0.020 |
Why?
|
| Cortisone | 1 | 2008 | 87 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2007 | 3733 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2010 | 411 | 0.020 |
Why?
|
| Metabolome | 1 | 2015 | 982 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 14490 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2008 | 79 | 0.020 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 2007 | 58 | 0.020 |
Why?
|
| Ribonuclease III | 1 | 2010 | 279 | 0.020 |
Why?
|
| Mixed Function Oxygenases | 1 | 2009 | 265 | 0.020 |
Why?
|
| Iron Chelating Agents | 1 | 2008 | 138 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2012 | 2497 | 0.020 |
Why?
|
| Codon, Nonsense | 1 | 2009 | 281 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 1332 | 0.020 |
Why?
|
| Collagen | 1 | 2016 | 2635 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2007 | 317 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2021 | 5460 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2008 | 522 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2012 | 1553 | 0.020 |
Why?
|
| Receptors, Transferrin | 1 | 2008 | 291 | 0.020 |
Why?
|
| Hydrogels | 1 | 2012 | 723 | 0.020 |
Why?
|
| Mast Cells | 1 | 2014 | 1390 | 0.020 |
Why?
|
| Mesoderm | 1 | 2010 | 672 | 0.020 |
Why?
|
| Staurosporine | 1 | 2007 | 242 | 0.020 |
Why?
|
| Aorta | 1 | 2014 | 2037 | 0.020 |
Why?
|
| United States | 3 | 2021 | 72136 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2001 | 3526 | 0.020 |
Why?
|
| Hydroxylation | 1 | 2006 | 137 | 0.020 |
Why?
|
| Multigene Family | 1 | 2010 | 1076 | 0.020 |
Why?
|
| RNA Stability | 1 | 2008 | 331 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 2221 | 0.020 |
Why?
|
| Health Personnel | 1 | 2020 | 3312 | 0.020 |
Why?
|
| Thrombocytosis | 1 | 2006 | 81 | 0.020 |
Why?
|
| Proteomics | 1 | 2020 | 3816 | 0.020 |
Why?
|
| Thrombopoietin | 1 | 2008 | 226 | 0.020 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2006 | 105 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2021 | 4641 | 0.020 |
Why?
|
| Wnt Proteins | 1 | 2010 | 719 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2014 | 1659 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2011 | 1674 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2011 | 1335 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2013 | 1866 | 0.020 |
Why?
|
| Receptors, Cytokine | 1 | 2006 | 258 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2013 | 1398 | 0.020 |
Why?
|
| Indoles | 1 | 2013 | 1828 | 0.020 |
Why?
|
| Gene Amplification | 1 | 2010 | 1085 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2003 | 6313 | 0.020 |
Why?
|
| Cycloheximide | 2 | 1996 | 343 | 0.020 |
Why?
|
| Hydrogen Bonding | 2 | 1996 | 290 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2012 | 1723 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 1995 | 2638 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2007 | 1229 | 0.010 |
Why?
|
| Osteoblasts | 1 | 2010 | 1142 | 0.010 |
Why?
|
| CHO Cells | 2 | 1998 | 1389 | 0.010 |
Why?
|
| Cell Movement | 1 | 2016 | 5201 | 0.010 |
Why?
|
| Elasticity | 1 | 2006 | 652 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 9273 | 0.010 |
Why?
|
| Finite Element Analysis | 1 | 2006 | 428 | 0.010 |
Why?
|
| Genetic Loci | 1 | 2013 | 2612 | 0.010 |
Why?
|
| Internet | 1 | 2016 | 3082 | 0.010 |
Why?
|
| Memory | 1 | 2013 | 2179 | 0.010 |
Why?
|
| Epidermis | 1 | 2006 | 528 | 0.010 |
Why?
|
| Cricetinae | 2 | 1998 | 2426 | 0.010 |
Why?
|
| Motor Activity | 1 | 2013 | 2685 | 0.010 |
Why?
|
| Horseradish Peroxidase | 1 | 1983 | 166 | 0.010 |
Why?
|
| Peroxidases | 1 | 1983 | 134 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 3615 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1994 | 1055 | 0.010 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 1983 | 110 | 0.010 |
Why?
|
| Liver | 3 | 2007 | 7502 | 0.010 |
Why?
|
| Lung | 1 | 2021 | 9985 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2014 | 3806 | 0.010 |
Why?
|
| Mouth Mucosa | 1 | 2005 | 426 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 5331 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 3617 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2010 | 3156 | 0.010 |
Why?
|
| Aminolevulinic Acid | 1 | 2003 | 142 | 0.010 |
Why?
|
| Metaplasia | 1 | 2003 | 321 | 0.010 |
Why?
|
| Circular Dichroism | 2 | 1998 | 344 | 0.010 |
Why?
|
| Protein Kinases | 1 | 2008 | 1610 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 2018 | 4673 | 0.010 |
Why?
|
| Organ Size | 1 | 2006 | 2252 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 2001 | 6852 | 0.010 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1983 | 411 | 0.010 |
Why?
|
| Obesity | 1 | 2023 | 12870 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 2008 | 1802 | 0.010 |
Why?
|
| Liver Neoplasms | 4 | 2001 | 4313 | 0.010 |
Why?
|
| Length of Stay | 1 | 2014 | 6439 | 0.010 |
Why?
|
| Skin | 1 | 2014 | 4464 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 4901 | 0.010 |
Why?
|
| Research Design | 1 | 2016 | 6157 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8611 | 0.010 |
Why?
|
| Mitosis | 1 | 2005 | 1191 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 1983 | 728 | 0.010 |
Why?
|
| Synaptic Membranes | 1 | 1999 | 89 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2006 | 1230 | 0.010 |
Why?
|
| Receptors, GABA-B | 1 | 1999 | 58 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 7378 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 10146 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1999 | 366 | 0.010 |
Why?
|
| Anxiety | 1 | 2013 | 4539 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 3227 | 0.010 |
Why?
|
| Photosensitizing Agents | 1 | 2003 | 618 | 0.010 |
Why?
|
| Photoaffinity Labels | 1 | 1998 | 85 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2008 | 2621 | 0.010 |
Why?
|
| Potentiometry | 1 | 1997 | 10 | 0.010 |
Why?
|
| Photochemistry | 1 | 1998 | 239 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2010 | 3664 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 1995 | 2292 | 0.010 |
Why?
|
| Anticonvulsants | 2 | 1998 | 1881 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1999 | 1317 | 0.010 |
Why?
|
| Hyperthermia, Induced | 1 | 2001 | 416 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 2690 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1980 | 673 | 0.010 |
Why?
|
| Ileum | 1 | 1999 | 555 | 0.010 |
Why?
|
| Endocytosis | 1 | 2001 | 958 | 0.010 |
Why?
|
| Dithiothreitol | 1 | 1996 | 95 | 0.010 |
Why?
|
| Colitis, Ulcerative | 1 | 2008 | 1919 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 4342 | 0.010 |
Why?
|
| Crohn Disease | 1 | 2008 | 2275 | 0.010 |
Why?
|
| Plasmids | 1 | 2001 | 2275 | 0.010 |
Why?
|
| Body Weight | 1 | 2006 | 4603 | 0.010 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2003 | 1489 | 0.010 |
Why?
|
| DNA Probes | 1 | 1996 | 543 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 1999 | 924 | 0.010 |
Why?
|
| RNA, Small Nuclear | 1 | 1995 | 74 | 0.010 |
Why?
|
| Receptors, Muscarinic | 1 | 1995 | 157 | 0.010 |
Why?
|
| TATA Box | 1 | 1994 | 127 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 1999 | 1197 | 0.010 |
Why?
|
| Pregnancy Proteins | 1 | 1995 | 222 | 0.010 |
Why?
|
| Cyanides | 1 | 1994 | 82 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1995 | 778 | 0.010 |
Why?
|
| Intestines | 1 | 2003 | 1906 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 1995 | 747 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1995 | 1084 | 0.010 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 1995 | 278 | 0.010 |
Why?
|
| Deoxyribonuclease I | 1 | 1994 | 224 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2006 | 5952 | 0.010 |
Why?
|
| Thermodynamics | 1 | 1994 | 595 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2001 | 2943 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1995 | 617 | 0.010 |
Why?
|
| Endothelial Growth Factors | 1 | 1995 | 672 | 0.010 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2007 | 3217 | 0.010 |
Why?
|
| Lymphokines | 1 | 1995 | 926 | 0.010 |
Why?
|
| Electron Spin Resonance Spectroscopy | 2 | 1983 | 162 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1997 | 1036 | 0.010 |
Why?
|
| Neurons | 1 | 1991 | 9416 | 0.010 |
Why?
|
| Biological Evolution | 1 | 1997 | 1074 | 0.010 |
Why?
|
| Biopsy | 1 | 2003 | 6768 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 2007 | 4312 | 0.010 |
Why?
|
| Tritium | 1 | 1991 | 707 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 1991 | 460 | 0.010 |
Why?
|
| Autoradiography | 1 | 1991 | 730 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2001 | 2821 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1991 | 2090 | 0.010 |
Why?
|
| Drosophila | 1 | 1997 | 1491 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2001 | 3485 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1994 | 4169 | 0.000 |
Why?
|
| Transforming Growth Factor beta | 1 | 1995 | 1958 | 0.000 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1996 | 3759 | 0.000 |
Why?
|
| Recombinant Proteins | 1 | 1995 | 6520 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1994 | 3680 | 0.000 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 1995 | 3480 | 0.000 |
Why?
|
| Aminopyrine | 1 | 1983 | 6 | 0.000 |
Why?
|
| Spectrophotometry, Infrared | 1 | 1980 | 116 | 0.000 |
Why?
|
| Protein Denaturation | 1 | 1980 | 242 | 0.000 |
Why?
|
| Viscosity | 1 | 1980 | 335 | 0.000 |
Why?
|
| Disulfides | 1 | 1980 | 465 | 0.000 |
Why?
|
| Rabbits | 1 | 1983 | 4772 | 0.000 |
Why?
|
| Cysteine | 1 | 1980 | 893 | 0.000 |
Why?
|
| Temperature | 1 | 1980 | 2219 | 0.000 |
Why?
|